Background: Hypoxic-ischemia (HI) and inflammation are the two major pathogenic mechanisms of brain injury in very preterm infants. The neurovascular unit is the major target of HI injury in the immature brain. Systemic inflammation may worsen HI by up-regulating neuroinflammation and disrupting the blood-brain barrier (BBB). Since neurons and oligodendrocytes, microvascular endothelial cells, and microglia may closely interact with each other, there may be a common signaling pathway leading to neuroinflammation and neurovascular damage after injury in the immature brain. TNF-α is a key pro-inflammatory cytokine that acts through the TNF receptor (TNFR), and c-Jun N-terminal kinases (JNK) are important stress-responsive kinases. Objective: To determine if TNFR1-JNK signaling is a shared pathway underlying neuroinflammation and neurovascular injury after lipopolysaccharide (LPS)-sensitized HI in the immature brain.
Background
Human studies and animal models have provided evidence on the detrimental roles of hypoxic-ischemia (HI) and inflammation to the brain of very preterm infants [1] [2] [3] . Preterm infants experience various HI and infectious insults during the neonatal period, with such infections predisposing to or aggravating HI. Clinical studies have shown that increased levels of systemic cytokines in premature infants with chorioamnionitis are associated with hemodynamic disturbances leading to cerebral HI, whereas co-morbid chorioamnionitis and placental perfusion defects put preterm infants at higher risk of abnormal neurologic outcomes than either insult alone [4] [5] [6] . HI and infectious events across the perinatal and neonatal periods have cumulative effects on the risk of cerebral palsy in very preterm infants [7] . Animal studies also show that preexposure to systemic lipopolysaccharide (LPS) sensitizes HI injury in the immature brain [8, 9] .
The major target of ischemia-reperfusion injury is the neurovascular unit, which is composed of neurons, oligodendroglia and microvessels [9, 10] . Neuronal or oligodendroglial apoptosis, microvascular damage, that is blood-brain barrier (BBB) disruption, and microglial activation have been linked to the severity of HI injury in the immature brain [8, 9, 11, 12] . For very premature infants, the O4-positive pre-myelinating oligodendrocyte progenitors are the target cells of white matter injury [13] . Activated microglia are the hallmark of neuroinflammation and may exacerbate brain injury through damage to the neurovascular unit [14, 15] . During detrimental insults, activated microglia may induce gray matter and white matter injury through the production of pro-inflammatory cytokines, such as TNF-α [1] . The damaged microvessels may recruit activated leukocytes into the injured brain through the disrupted BBB, resulting in sustained activation of microglia, which in turn cause further damage through prolonged production of pro-inflammatory cytokines [15] . Since neurons and oligodendrocyte progenitors, microvascular endothelial cells, and microglia may closely interact with each other, there may be a common signaling pathway leading to neuroinflammation and neurovascular damage after insults. Therefore, blocking such common signal transduction to reduce neuroinflammation and attenuate neurovascular damage may effectively provide neuroprotection to the immature brain.
c-Jun N-terminal kinases (JNK) are important stressresponsive kinases [16] . Our previous study has shown that JNK signaling is the shared pathway linking neuroinflammation, BBB disruption, and oligodendroglial apoptosis in the white matter injury of the immature rat brain [9] . However, the upstream pathway leading to JNK activation in neuroinflammation and in the cells of the neurovascular unit remains unclear. TNF-α is a key pro-inflammatory cytokine in the pathogenesis of brain injury in premature infants [1, 17, 18] , TNF-α and JNK activation precede cell death by inflammation and apoptosis [16, 19] . TNF-α signaling triggers inflammatory gene expression and JNKmediated intrinsic/extrinsic apoptotic cascades, while JNK activation can further stimulate TNF-α synthesis through AP-1 transcription [16, 19] . TNF-α exerts its biologic effects by signaling through two receptors, the TNF receptor (TNFR) 1 and TNFR2, which are detected in affected brain areas in preterm infants with periventricular leukomalacia [18] . Constitutively expressed in various neural and endothelial cells, TNFR1 are involved in inflammatory and apoptotic processes, while TNFR2 expression is often induced by injury and may have the opposite effects [19, 20] . TNF-α and JNK activation have been respectively reported to play roles in microglia-mediated neuroinflammation or BBB permeability [1, 9, 21] . Inhibition of either TNF-α-TNFR1 or JNK signaling exerts neuroprotective effects against HI brain injury in animal experiments [22, 23] . Therefore, TNF-α and JNK signal transduction may have cross-talk in the pathogenesis of HI-induced neuroinflammation and neurovascular injury in the immature brain.
Our studies have demonstrated that JNK activation plays important roles in LPS-sensitized HI injury in the neurovascular unit of the immature rat brain [8, 9] . However, it remains unclear whether TNFR1-JNK signaling is the shared pathway linking neuroinflammation and neurovascular damage after LPS-sensitized HI. Thus, using pharmacologic and genetic approaches in postpartum (P) day-5 mouse pups (brain maturation status equivalent to human gestation < 30 weeks), this study tested the hypothesis that TNFR1-JNK signaling is a shared pathway leading to neuroinflammation, microvascular damage, and neuronal and oligodendrocyte progenitor apoptosis in LPS-sensitized HI injury of the immature brain.
Methods

Establishing a mouse model of LPS-sensitized hypoxicischemic injury in the immature brain
This animal study was approved by the Animal Care Committee of National Cheng Kung University. The experimental paradigm adapted from Vannucci's HI method [24] was modified to include LPS sensitization in P5 mice. The brain maturation of P5 mice developmentally corresponds to very preterm infants, and has apoptotic and cell death mechanisms characteristic of the immature brain after HI [25] . P5 mouse pups (C57BL/6) were first injected intraperitoneally (ip) with LPS (Escherichia coli 055:B5; Sigma-Aldrich, St Louis, MO, USA) or pyrogen-free normal saline (NS). The pups were then randomly assigned to 3 different groups: control (NS injected without HI), NS + HI (NS injected 3 hours before HI), and LPS + HI (LPS 0.05 mg/kg injected 3 hours before HI). To avoid LPS-induced body temperature changes, the mouse pups were returned to their dams after LPS or NS injection, and housed in an incubator to maintain body temperature at 33 to 34°C before HI.
The HI was induced by right carotid artery ligation followed by hypoxia [8, 9] . The right common carotid artery was permanently ligated under 2.5% halothane anesthesia. The average length of surgery to occlude the artery was 2 minutes. After surgery, the pups were put into an incubator for a 1-hour recovery. They were then placed in airtight 500-mL containers partially submerged in a 36°C water bath, with humidified 8% oxygen kept at a flow rate of 3 L/minute for 30 minutes. Following hypoxia, the pups were returned to their dam. Technicians performed the experiments, while investigators blinded to the grouping performed the quantitative measurements.
Pharmacological inhibition of TNF-α
Etanercept is a non-selective TNF-α inhibitor that prevents TNF-α binding to TNFR by neutralizing the actions of soluble and transmembrane TNF-α [26] . The P5 mouse pups were randomly assigned to the control group (without exposure to LPS + HI), and the 3 LPS + HI groups that received ip injection of 5 or 15 mg/kg of etanercept (Enbrel, Wyeth Europa Ltd., Maidenhead, Berkshire, UK) or vehicle (NS) at 30 minutes before, immediately, and 3 hours after LPS + HI. The etanercept doses used were modified from Aden's study [27] .
TNFR1/TNFR2 knockout mice TNFR1-and TNFR2-knockout (KO) mice were bought from the Jackson Laboratory (Bar Harbor, ME, USA). The donor strains of TNFR1-and TNFR2-KO mice were from 129S2 via D3 ES cell line with a homozygous × homozygous mating system with a C57BL/6 genetic background.
Pharmacological inhibition of JNK
AS601245, a highly specific JNK inhibitor, blocks JNK activity by binding to its ATP-binding site [28] . The P5 pups were randomly assigned to the control group (without exposure to LPS + HI) and the 3 LPS + HI groups that received ip injection of 20 or 40 mg/kg of AS601245 (Alexis Biochemicals, Lausen, Switzerland) or vehicle (dimethyl sulfoxide (DMSO), Sigma-Aldrich, St Louis, MO, USA) at 30 minutes before and immediately after LPS + HI. The doses of AS601245 used were modified from Carboni's study [28] .
Western blot analysis
The ipsilateral hemisphere was homogenized in cold lysis buffer and the protein concentrations were determined using a Bio-Rad Protein Assay kit (Bio-Rad Laboratories, Hercules, CA, USA). Samples (50 μg) were separated using 10% SDS-PAGE and blotted onto polyvinylidene fluoride membranes. The membranes were incubated with primary antibodies. Immunoreactivity was detected by horseradish-conjugated secondary antibodies and visualized by enhanced chemiluminescence. The primary antibodies used were anti-TNF-α (1:500; Biolegend, San Diego, CA, USA), anti-phospho-JNK (p-JNK) (Thr183/Tyr185, 1:1,000; Cell Signaling, Danvers, MA, USA), anti-cleaved caspase 3 (1:1,000; Cell Signaling, Danvers, MA, USA), and anti-β-actin (1:5,000; Invitrogen, Carlsbad, CA, USA). The band signals were quantified using an imaging software (ImagePro Plus 6.0; Media Cybernetics, Bethesda, MD, USA).
Immunohistochemistry
Mouse pups were sacrificed and perfused for cryosections on P6 (24 hours post-insult). The brains were postfixed, dehydrated using 30% (w/v) sucrose in PBS, and coronally sectioned (20-μm thick) from the genu of the corpus callosum to the end of the dorsal hippocampus. Three sections per brain, one at the level of the striatum (0.14 mm anterior to the bregma) and another 2 at the levels of the dorsal hippocampus (1.94 mm and 2.54 mm posterior to the bregma) according to a mouse brain atlas [29] , were selected for immunohistochemical staining.
Immunohistochemistry was performed for microglial activation (ionized calcium-binding adaptor molecule-1, Iba-1), immunoglobulin G (IgG) extravasation, cleaved caspase-3, p-JNK, TNFR1 and TNFR2. IgG extravasation was used as an indicator of BBB permeability [30] . After eradication of endogenous peroxidases and blocking of non-specific binding, brain sections were incubated at 4°C overnight with one of the following primary antibodies: anti-Iba-1 (1:1,000, Wako, Richmond, VA, USA), horseradish peroxidase-conjugated anti-mouse IgG (1:100; Pierce, Rockford, IL, USA), anti-cleaved caspase-3 (1:100; Cell Signaling, Danvers, MA, USA), anti-p-JNK (1:100; Cell Signaling, Danvers, MA, USA), anti-TNFR1 (1:200; Abcam, Cambridge, MA, USA), and anti-TNFR2 (1:100; Abnova, Walnut, CA, USA). After incubation with biotinylated secondary antibodies (anti-rabbit IgG 1:200; Pierce, Rockford, IL, USA), biotin-peroxidase signals were detected using 0.5 mg/mL 3′3′-diaminobenzidine (DAB)/0.003% H 2 O 2 as a substrate. The results were recorded using a microscope (BX51; Olympus, Tokyo, Japan).
Assessment of cortical and white matter injury
On P17 (12 days post-insult), the brains were post-fixed, dehydrated and embedded in paraffin, and then coronally sectioned (10-μm thick) from the genu of the corpus callosum to the end of the dorsal hippocampus. Three sections per brain as described above were assessed.
Cortical damage
Nissl-stained sections were scanned and the cortical areas were measured using ImagePro Plus 6.0 (Media Cybernetics, Bethesda, MD, USA). The percentage of area loss in the cortex of the ipsilateral versus the contralateral hemisphere was calculated [8] .
White matter injury
White matter injury was evaluated by myelin basic protein (MBP) staining for myelination and glial fibrillary acidic protein (GFAP) staining for astrogliosis. After permealization and blocking of non-specific binding, sections were first incubated at 4°C overnight with the primary rat monoclonal anti-MBP antibody (1:100; Millipore, Billerica, MA, USA) or rabbit polyclonal anti-GFAP antibody (1:800; Millipore, Billerica, MA, USA), rinsed, and then incubated with biotinylated goat anti-rat (1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA) or anti-rabbit (1:300; Pierce Biotechnology, Rockford, IL, USA) IgG. Positivelystained cells were visualized using avidin-biotin-peroxidase complex amplification (Pierce Biotechnology, Rockford, IL, USA) with diaminobenzidine tetrahydrochloride detection. The MBP expression was assessed in 3 regions within the white matter in each hemisphere of each section at 100× magnification per visual field (0.579 mm 2 ), and graded using a 4-point scoring system: 0, loss of processes and complete loss of the capsule; 1, loss of processes with thinning or breaks in the capsule; 2, complete loss of processes with intact capsule; 3, partial loss of processes; and 4, no MBP loss [8, 9] . The scores of each region were summed up to obtain a total score (range, 0 to 12) for each hemisphere. ) and analyzed using ImagePro Plus 6.0 [8, 9] . Three visual fields in the medial, middle, and lateral areas of the ipsilateral cortex per section, and three sections per brain as described above were analyzed. Iba1-positive cells with amoeboid morphology were counted as activated microglia for analysis. The mean IOD values in the ipsilateral hemisphere of each experimental group were compared to those of the control group to obtain the relative IOD ratios.
Quantitative analysis of immunohistochemical staining
Immunofluorescence
Mouse pups in the LPS + HI group were perfused at 24 hours post-insult. After blocking, the sections were incubated overnight at 4-°C with a mixture of 2 of the following primary antibodies: anti-mouse NeuN (1:100; Millipore, Billerica, MA, USA,), mouse monoclonal anti-O4 immunoglobulin M (IgM) (1:100; Millipore, Billerica, MA, USA), anti-isolectin IB4 Alexa Fluor 594 (1:200; Invitrogen, Carlsbad, CA, USA), anti-Iba-1 (1:1,000; Wako, Richmond, VA, USA), anti-cleaved caspase-3 (1:100; Cell Signaling, Danvers, MA, USA), anti-TNF-α (1:100; Biolegend, San Diego, CA, USA), anti-p-JNK (1:100; Cell Signaling, Danvers, MA, USA), and anti-TNFR1 (1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA). The sections were washed and then incubated with Alexa Fluor 594 or 488 secondary antibodies (1:400; Invitrogen, Carlsbad, CA, USA). The slides were photographed for red (Alexa Fluor 594) and green (Alexa Fluor 488) fluorescence with a fluorescent microscope (E400; Nikon Instech, Kawasaki, Japan).
Statistical analysis
Statistical significance (P < 0.05) was determined using the Kruskal-Wallis test, and Dunn's method was used for post-hoc comparisons. Continuous data were presented as means ± standard errors of mean (SEM).
Results
LPS sensitized hypoxic-ischemic injury in the immature brain
The cortical and white matter injuries in P5 mouse pups exposed to different HI durations (30 and 40 minutes) were first determined. Neuropathologic examinations performed on P17 showed that the pups exposed to 40-minute (40% mortality) HI, but not to 30-minute (5.6% mortality) HI, had significant brain area loss ( Figure 1A , upper panel) and reduced MBP expression ( Figure 1A , middle panel) in the ipsilateral hemisphere compared to the control pups without HI exposure. The 30-and 40-minute HI and the control groups had similar MBP expression in the contralateral hemispheres ( Figure 1A , lower panel). Thus, 30-minute HI was used for the LPSsensitized HI experiments.
Next, we determined whether LPS injection alone induced brain injury. Neuropathologic examinations on P17 showed that the 0.05-mg/kg and 0.5-mg/kg LPS groups had no significant injury in the cortex ( Figure 1B , upper panel) and white matter ( Figure 1B , middle and lower panels) compared to the NS group. Then, we examined the LPS effect on HI mortality. After HI, the 0.5-mg/kg LPS group had significantly higher mortality than the 0.05-mg/kg LPS group (32.3% versus 13.1%, P < 0.05). Figure 1 Effects of hypoxic-ischemia (HI) or lipopolysaccharide (LPS) alone on brain injury. Mouse pups were exposed to different duration of HI or different doses of LPS on P5, and neuropathological examinations were performed on P17. (A) Compared to the control groups (n = 6), pups exposed to 40 minute-HI (n = 9), but not to 30-minute HI (n = 10), had significant injury in the cortex (upper panel) and decreased myelin basic protein (MBP) expression in the white matter of the ipsilateral hemispheres (middle panel). There were no significant differences in MBP expression in the contralateral white matter among the control, 30-minute HI and 40-minute HI groups (lower panel). (B) Compared to the normal saline (NS) group (n = 5), the 0.05-mg/kg LPS (n = 5) and 0.5-mg/kg LPS (n = 5) groups showed no evident cortical (Nissl staining, upper panel) or white matter injury (MBP staining, middle and lower panels). Scale bar = 200 μm. Values are means ± SEM. **P < 0.01, ***P < 0.001. Therefore, 0.05-mg/kg LPS was chosen for the following LPS-sensitized HI experiments on brain injury. On P17, the LPS + HI group had significantly more cortical damage, white matter injury with decreased MBP expression, and increased astrogliosis than the control and NS + HI groups (Figure 2A) .
LPS-sensitized hypoxic-ischemia up-regulated neuroinflammation and TNF-α, and worsened neurovascular damage At 24 hours post-insult, the LPS + HI group, rather than the NS + HI group, had significantly increased Iba1-positive activated microglia and BBB damage (IgG extravasation) ( Figure 2B ). The effects of LPS and LPS + HI on TNF-α expression were examined using immunoblotting.
Compared to NS, LPS injection before HI did not increase TNF-α levels ( Figure 2C, upper panel) . In contrast, after LPS-sensitized HI, the TNF-α levels were significantly increased at 3 hours, and especially at 24 hours after HI ( Figure 2C, lower panel) . The LPS + HI pups also had significantly more up-regulation of TNF-α ( Figure 2D , upper panel) and cleaved caspase-3 levels ( Figure 2D , lower panel) at 24 hours post-insult compared to the NS + HI pups. Further immunofluorescence study in the LPS + HI group showed that Iba1-positive microglia highly expressed TNF-α (Figure 3 ). Cleaved caspase-3 was highly expressed in the IB 4 -positive microvascular endothelial cells, NeuN-positive neurons, and O4-positive oligodendroglial precursor cells, indicating that these cells were undergoing apoptosis (Figure 3 ). 
LPS-sensitized hypoxic-ischemia induced JNK activation in microglia, microvascular endothelial cells, neurons, and oligodendrocyte progenitors
Immunoblotting demonstrated persistent JNK activation at 6 and 24 hours post-insult in the LPS + HI group, but not in the NS + HI group ( Figure 4A ). Immunofluorescence study in the LPS + HI group further revealed up-regulation of p-JNK expression in activated microglia, microvascular endothelial cells, neurons, and oligodendrocyte progenitors at 24 hours post-insult ( Figure 4B ). In addition, there were many p-JNK-positive cells (green light) attached to or located around the IB 4 -positive microvessels (arrowheads in Figure 4B ).
TNF-α inhibition protected against LPS-sensitized hypoxic-ischemic brain injury
Compared to vehicle, etanercept significantly attenuated cortical injury at a dose of 15 mg/kg but not at 5 mg/kg treatment in the LPS + HI group, and preserved MBP expression and reduced astrogliosis in the white matter on P17 ( Figure 5A ).
TNFR1 was up-regulated in microglia, microvascular endothelial cells, neurons, and oligodendrocyte progenitors after LPS-sensitized hypoxic-ischemia
We further investigated which of the two TNF-α receptors (TNFR1 and TNFR2) played a predominant role in LPS-sensitized HI brain injury. Immunohistochemistry in the LPS + HI group showed significant up-regulation of TNFR1 but not of TNFR2 expression in the cortex and white matter 24 hours post-insult ( Figure 5B ). Immunofluorescence showed that TNFR1 was expressed mainly in the microglia, endothelial cells, neurons and oligodendrocyte progenitors, and most of the TNFR1-positive cells also co-expressed p-JNK ( Figure 6 ).
TNFR1 but not TNFR2 down-regulation reduced JNK activation, attenuated neuroinflammation and neurovascular damage, and ameliorated brain injury after LPS-sensitized hypoxic-ischemia
The TNFR1-KO pups, but not the TNFR2-KO pups, had significantly reduced p-JNK expression, with decreased activated microglia, BBB breakdown, and cleaved caspase-3- positive cells compared to the wild-type pups at 24 hours post-insult ( Figure 7A ). On P17, the TNFR1-KO mice, but not the TNFR2-KO mice, had significant attenuation of cortical and white matter injury with decreased astrogliosis compared to the wild-type mice ( Figure 7B ).
Suppression of JNK activation protected against LPS-sensitized hypoxic-ischemic brain injury
The effect of JNK inhibition on LPS-sensitized HI injury was then examined using AS601245, an ATP-competitive inhibitor of JNK. Compared to vehicle, AS601245 treatment in the LPS + HI group at a dose of 20 mg/kg was more effective than a dose of 40 mg/kg in attenuating cortical damage, preserving MBP expression, and reducing astrogliosis on P17 (Figure 8 ).
Discussion
Neonatal pre-exposure to systemic inflammation may affect cerebral vulnerability and thereby act concomitantly with HI insult to aggravate brain injury [31] . The present study demonstrated that P5 mouse pups, equivalent to very preterm infants in brain maturation status, subjected to the combination of LPS and HI had cortical and white matter injury on P17. The damage was characterized by apoptosis of neurons and oligodendrocyte progenitors, BBB disruption, and microglial activation in association with the selective up-regulation of TNFR1 and activation of JNK. Furthermore, the up-regulated TNFR1 and p-JNK were co-localized in the cellular component of the neurovascular unit (neurons, oligodendroglial precursors, and (B) The LPS + HI groups (n = 8) had significantly increased immunoreactivity of TNFR1 but not TNFR2 in the cortex (upper panel) and white matter (lower panel) 24 hours post-insult compared to the control groups (n = 6). The up-regulated TNFR1 was expressed in blood vessels (arrows) and non-vascular cells. Scale bar = 200 μm for MBP and 100 μm for others. Values are means ± SEM. ***P < 0.001, **P < 0.01, *P < 0.05. GFAP, glial fibrillary acidic protein; MBP, myelin basic protein; TNFR, tumor necrosis factor receptor. microvascular endothelial cells) and microglia. Inhibition of TNF-α or JNK activity exerted significant neuroprotection. More importantly, genetic deficiency of TNFR1, but not TNFR2, suppressed JNK activation, reduced neuronal and oligodendroglial apoptosis, attenuated BBB breakdown and microglial activation, and protected against cortical and white matter injury. These findings suggest that TNFR1-JNK signaling is a shared pathway linking neurovascular damage and neuroinflammation that contribute to LPS-sensitized HI injury in the immature brain.
Neurons and vascular cells are closely related developmentally and functionally [32] . Communication between the nervous and vascular systems is required to maintain the integrity of the BBB and promote neural function in the developing brain [33] . Neurons, oligodendrocyte progenitors, and microvascular endothelial cells form a close, inter-related neurovascular unit in the cortex and white matter, which may be the major targets of injury in the immature brain [8, 9, 11, 12] . Damage to the neurons and microvasculature may occur progressively after HI [34] . After insults, damaged microvessels may recruit activated leukocytes into the injured brain through the disrupted BBB, leading to sustained neuroinflammation, which in turn further damages the brain and microvasculature through prolonged production of pro-inflammatory cytokines [15] . As such, neurovascular damage and neuroinflammation are two mutually-potentiating mechanisms leading to injury in the developing brain.
Previous studies have found that inflammation alone, even at moderate levels (repeated 0.01-mg/kg IL-β or 0.3-mg/kg LPS injection), caused injury in the developing brain [35, 36] . The present study showed that a single LPS injection alone at a lower dose (0.05 mg/kg) did not induce brain injury. However, the low-dose LPS can sensitize neurovascular damage and worsen brain injury after HI via the TNFα-TNFR1-JNK pathway. Studies investigating the mechanisms of LPS sensitization demonstrate early up-regulation of genes that are associated with stress-induced inflammatory response and cell death in the neonatal brain several hours after peripheral exposure to LPS, with the priming effect contributing to increased vulnerability of the immature brain to subsequent insults [37, 38] . The TNF-α pathway plays a key role in inflammation-sensitized excitotoxic brain injury in neonatal mice [27] . TNF-α gene cluster deletion abolishes LPS-mediated sensitization of the neonatal brain to HI insult [38] . Similarly, an in vitro study has shown that TNFR1 signaling is essential for LPS-induced sensitization to oxygen-glucose deprivation in murine neonatal organotypic hippocampal slices [39] . Another in vitro study also found that oxygen-glucose deprivation enhanced TNF-α/ IFN-γ toxicity via up-regulation of TNF-related apoptosisinducing ligand signaling in both neuronal and oligodendrocyte progenitor cell cultures [40] .
Our previous study showed that JNK activation is involved in LPS-sensitized HI injury in the immature brain [9] . However, the upstream pathway leading to JNK activation remains unclear. Nijboer's work showed JNK inhibition protected against HI brain injury in P7 rat pups [23] . They revealed that JNK inhibition did not reduce HI-induced cytokine expression including TNF-α, suggesting JNK might not only be one of the downstream pathways of TNF-α signaling but also involved in HI injury of the neonatal brain [23] . Our present study on the respective role of TNF-α, TNFR and JNK in LPS-sensitized HI injury of P5 mice demonstrates that TNF-α-triggered TNFR1-JNK activation is a critical shared pathway leading to neuroinflammation and neurovascular injury after LPSsensitized HI in the immature brain.
Activated microglia play a central role as a converging point for upstream HI/inflammation and downstream cytotoxicity in the pathogenesis of neurovascular injury in the immature brain [1, 14] . The present study demonstrates TNF-α, TNFR1, and JNK up-regulation, and microglial activation post-insult, with co-localization of TNFR1 and p-JNK in the activated microglia. A previous study has shown that JNK activation in microglia triggered by LPS-sensitized HI is associated with nuclear translocation of the downstream molecule c-Jun, suggesting the neuroinflammatory role of microglia [9] . p-JNK-positive activated microglia then release TNF-α, which may not only exert cytotoxic effects on endothelial cells, neurons, and oligodendrocyte progenitors, but also facilitate prolonged microglial activation by promoting JNK synthesis through TNFR1 in an autocrine loop [41] .
Systemic application of LPS alone induces up-regulation of pro-inflammatory cytokines in P7 mouse forebrain in association with strong activation of microglia and microvessels [38] . Deletion of the entire TNF gene cluster not only greatly attenuates endotoxin-mediated increase in cerebral infarct volume after HI, but also prevents microglial and endothelial activation following application of LPS alone [38] , suggesting the potential involvement of microglia and microvascular endothelial cells in LPSmediated sensitization to neonatal brain injury.
The TNF-α and JNK signaling may contribute to leukocyte-and microglia-driven BBB disruption [42] . Animal experiments demonstrate that stroke and subarachnoid hemorrhage can up-regulate TNF-α or JNK signaling for BBB permeability [21, 43] . In vitro studies also show the involvement of TNFR and JNK activation in the apoptosis of cerebral microvascular endothelial cells [44, 45] . In this study, LPS-sensitized HI induced perivascular aggregation of p-JNK-positive cells, which may be endogenous brain cells or peripheral leukocytes infiltrating through the disrupted BBB. During detrimental insults, p-JNK-positive activated leukocytes migrating into the brain may not only cause sustained BBB disruption by enhancing TNFα-mediated matrix metalloproteinase-9 activity [46] , but also result in prolonged activation of microglia, which in turn further damage the BBB through TNFR1 signaling by lasting TNF-α production and chemokine secretion to attract more leukocytes into the brain [15, 47] . Therefore BBB breakdown may act in concert with activated microglia to worsen LPS-sensitized HI injury.
Autopsy studies of periventricular leukomalacia have shown enhanced TNF-α expression in cortical neurons and that pre-myelinating oligodendrocytes are the major apoptotic cells in the white matter [13, 48] . TNFR1 is significantly up-regulated in apoptotic oligodendrocytes following hypoxia in neonatal rats [49] . In vitro studies also have shown that oligodendrocyte progenitors obtained from TNFR1/TNFR2-KO mice are resistant to LPS-induced microglial toxicity [50] , and TNFR1 is necessary for apoptosis of oxygen-glucose deprived cortical neurons [51] . Moreover, JNK activation plays an important role in stress-induced apoptosis of oligodendrocyte progenitors and HI neuronal death [23, 52] . In this neonatal mouse model, we showed that neurons, O4-positive oligodendrocyte precursor cells, and endothelial cells are the target of injury in the neurovascular unit after LPS-sensitized HI.
The co-localization of p-JNK and TNFR1 in apoptotic cells implicated the key role of TNFR1-JNK signaling in triggering death events in the neurovascular unit. The cytotoxic effects of TNF-α may be mediated directly through TNFR1 by formation of death-inducing signaling complex, or indirectly, via intrinsic/extrinsic apoptotic pathways induced by TNFR1-JNK activation [16, 19] . In addition to cell death, surviving oligodendrocyte progenitors may be deterred from proliferation and differentiation by microglial activation and reactive astrocytes [1] . Our findings of reactive astrogliosis and hypomyelination on P17 after LPSsensitized HI may imply the effects of neuroinflammation on impairment of oligodendroglial maturation.
Conclusion
In summary, TNFR1-JNK signaling is up-regulated after LPS-sensitized HI and acts as a shared pathway leading to neurovascular damage and neuroinflammation, which may potentiate with each other to worsen cortical and white matter injury in the immature brain (Additional file 1: Figure S1 ). Blocking the loop of TNFR1-JNK signaling effectively protects against inflammation-sensitized HI injury in the immature brain. Thus, TNFR1-JNK signaling may emerge as a potential therapeutic target for brain injury in very preterm infants.
Additional file
Additional file 1: Figure S1 . A proposed diagram showing the self-potentiating loop of TNFR1-JNK signaling in the pathogenesis of inflammation-sensitized hypoxic-ischemic neurovascular injury in the immature brain. Lipopolysaccharide-sensitized hypoxic-ischemia may damage the neurovascular units (neurons, oligodendrocyte progenitors, microvascular endothelial cells) and activate microglia in the immature brain via a shared TNFR1-JNK signaling pathway leading to sustained neuroinflammation, blood-brain barrier disruption and cell apoptosis in a vicious cycle. The white arrows indicate possible roles of TNF-α in triggering microglial activation, blood-brain barrier breakdown and cell apoptosis in a self-augmenting loop. JNK, c-Jun N-terminal kinases; TNF-α, tumor necrosis factor-alpha; TNFR1, TNF-α receptor 1.
Abbreviations BBB: blood-brain barrier; DAB: 3′3′-diaminobenzidine; DMSO: dimethyl sulfoxide; GFAP: glial fibrillary acidic protein; HI: hypoxic-ischemia; Iba-1: ionized calcium-binding adaptor molecule-1; IFN: interferon; IgG: immunoglobulin G; IgM: immunoglobulin M; IOD: integrated optical density; ip: intraperitoneal; JNK: c-Jun N-terminal kinase; KO: knockout; LPS: lipopolysaccharide; MBP: myelin basic protein; NS: normal saline; P: postpartum; PBS: phosphate-buffered saline; p-JNK: phospho-JNK; TNF-α: tumor necrosis factor-α; TNFR1: tumor necrosis factor receptor 1; TNFR2: tumor necrosis factor receptor 2.
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